Tags
- 3/5
- 4
- 4/6
- 5-12
- A
- ADT
- Adverse
- Adverse Events
- Alone
- Alternative
- Alternative approach
- Alway, Newport
- Always Be
- Amalya, Bhopal
- An
- Androgen
- Androgen deprivation therapy
- Androgen suppression
- AR
- Assessment
- Asymptomatic
- Baseline
- BRCA2
- Brca2 mutation
- Cancer
- Carrier
- Carriers
- CHEK2
- Clinical
- Clinical endpoint
- Combination
- Combinations
- Combination therapy
- Combined
- Comparable
- Concurrency
- Confidence interval
- Contribution
- Criteria
- Crucial
- Decline
- Defer
- Demonstration
- Deprivation
- Disease
- Early termination
- Efficacy
- Elevated transaminases
- Endpoint
- Endpoints
- Explore
- Exploring
- Factor
- Fatigue
- Focus
- Future research
- Gene inactivation
- Gene mutations
- Generalizability theory
- Germline
- Grade
- H
- Hao Wang
- Homologous recombination
- Homology
- Hormone
- Hormone-sensitive
- HRR
- Inactivation
- Induce
- Inhibition
- Inhibitor
- Insight
- Insights
- King
- L
- Laura Linville
- Limit
- Linville
- Lotan
- Maintenance, repair and operations
- Markowski
- Marshall Rana
- Mathematical optimization
- Maxima and minima
- MCRPC
- Metástasis
- Mutation
- Mutations
- N
- Normal distribution
- Novel
- Observation
- Oncology
- Optimize
- Option
- Paradigm
- PARP
- PARP inhibitor
- Participation
- Pathogen
- Patient
- Patient selection
- Pharmacovigilance
- Phase
- Phase II
- Phases of clinical research
- Poverty
- Primary
- Profile
- Progression-free survival
- Promise
- Prostate
- Prostate cancer
- Prostate cancer treatment
- PSA
- Publishing
- Radiography
- Rana Sullivan
- Recombination
- Refining
- Replace
- Research
- Research I university
- Response rate
- Result
- Revealed
- Rucaparib
- Safety
- Safety assessment
- Sample
- Sample size determination
- Sargsyan
- Secondary
- Secondary endpoints
- Select
- Selection
- Selection criteria
- Serina King
- Shown
- Sternberg
- Strategie
- Strategy
- Studie
- Suggest
- Sullivan Serina
- Summary
- Survival
- Takeaway
- Targeting
- Termination
- Therapy
- Threshold
- Treatment of cancer
- Treatment response
- Trial
- Trials
- Triumph
- Twice
- Understanding
- Unlikely
- Wang Laura
- When